Form 4 for PGEN PRECIGEN, INC.
Accepted 2021-07-20 00:00:00 ET · period of report 2021-07-17 · accession 0000950103-21-010821 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-20 | 2021-07-17 | PGEN | Sabzevari Helen | Pres, CEO, Dir | M - OptEx | — | +25.0K | 730.1K | +4% | — |
| D | 2021-07-20 | 2021-07-19 | PGEN | Sabzevari Helen | Pres, CEO, Dir | S - Sale+OE | $5.43 | -12.5K | 717.5K | -2% | -$68.0K |
| D | 2021-07-20 | 2021-07-17 | PGEN | Sabzevari Helen | Pres, CEO, Dir | M - OptEx | $0.00 | -25.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-17 | M | A | 25,000 | — | 730,057 | D | — | — | (F1) Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. |
| 2 | Common | Common Stock | 2021-07-19 | S | D | 12,531 | $5.43 | 717,526 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-07-17 | M | D | 25,000 | $0.00 | 0 | D | — · — to — | 25,000 Common Stock | (F1) Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. (F3) The RSUs were granted on March 28, 2018 and have vested in full. |